APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Chi-yuan Hsu, MDMeyeon Park, MD
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientists at UCSF
- Chi-yuan Hsu, MD
Dr. Hsu has been Chief of the Division of Nephrology at UCSF Health since 2007. His research spans acute, chronic and end-stage kidney disease and includes both observational studies and clinical trials. - Meyeon Park, MD
My research focuses on the early diagnosis of kidney hypoxia, injury, and disease and the influence of cardiovascular disease on kidney disease onset and progression. Clinically, I see patients with all manifestations of hypertension and kidney disease, with a special focus on patients with polycystic kidney disease.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Wake Forest University Health Sciences
- ID
- NCT03615235
- Study Type
- Observational
- Participants
- Expecting 5000 study participants
- Last Updated